Pharmacokinetics of panitumumab in a patient with liver dysfunction: a case report

被引：0

作者：

L. L. Krens

J. M. Baas

F. A. de Jong

H. J. Guchelaar

H. Gelderblom

机构：

[1] Leiden University Medical Center,Department of Clinical Pharmacy and Toxicology

[2] Leiden University Medical Center,Department of Clinical Oncology

[3] Amgen B.V.,Medical Department

[4] Merck Serono,HQ Medical Affairs

来源：

Cancer Chemotherapy and Pharmacology | 2014年 / 73卷

关键词：

Panitumumab; Liver dysfunction; Pharmacokinetics; Colorectal cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：429 / 433

页数：4

共 50 条

[1] Pharmacokinetics of panitumumab in a patient with liver dysfunction: a case report
Krens, L. L.
Baas, J. M.
de Jong, F. A.
Guchelaar, H. J.
Gelderblom, H.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (02) : 429 - 433
[2] Pharmacokinetics (PK) of panitumumab in a single patient with metastatic colorectal cancer (mCRC) and liver dysfunction
Krens, Lisanne
Baas, Jara
de Jong, Floris A.
Guchelaar, Henk-Jan
Gelderblom, Hans
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
[3] InsulinOedema in an elderly patient with severe liver dysfunction: case report
Reactions Weekly, 2003, 963 (1) : 11 - 11
[4] Case report: An hemophagocytic lymphohistiocytosis patient initiated with liver dysfunction
Zhang, Mingjun
Liu, Yulan
Rao, Huiying
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 181 - 181
[5] AcitretinAgranulocytosis (first report), alopecia and liver dysfunction in an elderly patient: case report
Reactions Weekly, 2002, 932 (1) : 6 - 6
[6] A Hemophagocytic Lymphohistiocytosis Patient Initiated with Prominent Liver Dysfunction: a Case Report
Ming-jun Zhang
Yu-lan Liu
ChineseMedicalSciencesJournal, 2014, 29 (03) : 191 - 193
[7] Oxatomide/terfenadineEczematous exanthema and liver dysfunction in an elderly patient: case report
Reactions Weekly, 2002, 913 (1) : 10 - 10
[8] Pharmacokinetics and safety of panitumumab in a patient with chronic kidney disease
Krens, L. L.
Baas, J. M.
Guchelaar, H. J.
Gelderblom, H.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 179 - 182
[9] Pharmacokinetics and safety of panitumumab in a patient with chronic kidney disease
L. L. Krens
J. M. Baas
H. J. Guchelaar
H. Gelderblom
Cancer Chemotherapy and Pharmacology, 2018, 81 : 179 - 182
[10] KetoconazoleExacerbation of liver dysfunction?: case report
Reactions Weekly, 2010, 1332 (1) : 25 - 25

← 1 2 3 4 5 →